Nitrosamines are a potent and versatile group of carcinogens and by the generally accepted mechanisms of their carcinogenicity require metabolic transformation to alkylating agents or carbonium ions before they become biologically active (Hultin et al., 1960; Heath, 1962). Metabolic studies of dimethylnitrosamine in the rat have shown that it was readily metabolized to CO, (Magee, 1956) and that the formation of COz related to the decomposition of dimethylnitrosamine obeyed the Michaelis-Menten kinetic equation (Heath, 1962) These observations were based on investigations conducted on female rats intraperitoneally administered with 14C-labelled dimethylnitrosamine at dose levels ranging from 16 to 50mg/kg body wt. We have extended these metabolic studies to include dose levels of 14C-labelled dimethylnitrosamine ranging fromO.l to 50mg/kg body wt. administered by three parenteral routes and by oral intubation to male and female rats. In addition, the rates of disappearance of dimethylnitrosamine from the stomach and small intestine of the rat have been investigated. Some preliminary results are presented on the effects of pretreatment with dimethylnitrosamine, phenobarbitone and 20-methylcholanthrene on the metabolism of dimethylnitrosamine in the rat.
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Wistar albino rats of both sexes (200-2508 body wt.) were used in these studies. Metabolic studies were done on male and female rats at dose levels of 14C-labelled dimethylnitrosamine ranging from 0.1 to 50mg/kg body wt. administered by the intraperitoneal, intravenous, subcutaneous routes or by gastric intubation. The animals were placed in metabolic cages provided with facilities for the collection of respired air and urine and at intervals of time following the administration of '4C-labelled dimethylnitrosamine, radioactivity was measured in the respired CO, and in urine.
Absorption studies of dimethylnitrosamine from the gastro-intestinal tract were done by using the operative techniques described by Matthews et al. (1968) and Casper et al. (1973) . Following the partial laparotomy of rats anaesthetized with nembutal, the stomach was ligated at both ends, care being taken to avoid occluding blood vessels, and an appropriate dose of 14C-labelled dimethylnitrosamine dissolved in 0.9 % NaCl solution was injected into the stomach. After an absorptive period ranging from 6 to 30min, the stomach was excised, cut open, washed with 0.9% NaCl solution and the radioactivity measured. Similarly, absorption from the small intestines was determined following the injection of appropriate doses of 14C-labelled dimethylnitrosamine dissolved in 0.9 %NaCI solution into ligated small intestinal loops 5cm long, selected between 10 and 30cm from the pylorus.
In the first series of experiments the rate and amount of 14C02 respired was determined following the intraperitoneal administration of 14C-labelled dimethylnitrosamine at doses of 0.1, 1 .O, 5 and 50mg/kg body wt. in male and femalerats. The total amount of 14C0, respired during 8 h at all doselevels investigatedand in both sexes was in the range of 57 to 59 % of the administered radioactivity. The 14C02 respiration rate in the intact animal was dose dependent and broadly obeyed the Michaelis-Menten kinetic equation, and the K,,, and V,,,. values obtained, 14.5mg/kg and 5.5nig/kg per h respectively, were comparable with those reported by Heath (1962) .
In the second series, the rate and amount of 14C0, respired was determined following the administration of 14C-labelled dimethylnitrosamine at a dose of 5nig/kg body wt., by the intraperitoneal, intravenous, subcutaneous and oral gavage rates to male and female rats. The amount of l4CO2 respired during 8 h by all four routes of administration in both sexes was about 57% of the administered dose and the 14C02 respiration rate of approximately 19 % of the dose/h was similar in all cases. The results of the gastro-intestinal absorption studies (Fig. 1) . showed that the absorption rate of 14C-labelled dimethylnitrosamine from the stomach was slow at all the doses investigated. Over 50% of the radioactivity remained unabsorbed 30min after the administration of 14C-labelled dimethylnitrosamine into the stomach of both 'fed' and 'starved' rats. In contrast, absorption of 14C-labelled dimethylnitrosamine from the small intestine was a comparatively rapid process and the greater part of the radioactivity was found to disappear over a period of 20min and less than 5 % could be found in the intestinal lumen over 30min. Additional evidence corroborating the observed slow rate of absorption of dimethylnitrosamine from the stomach was obtained from metabolic studies following the oral administration of 14C-labelled dimethylnitrosamine to rats with the stomach ligated at the pyloric end. The findings showed that there was a measurably lower rate of 14C02 excretion from the rats with ligated stomach compared with sham-operated animals.
VOl. 2
The rates of 14C02 excretion were determined following the intraperitoneal administration of 14C-labelled dimethylnitrosamine at a dose of 5mg/kg body wt. to rats pretreated either with unlabelled dimethylnitrosamine, phenobarbitone or 20-methylcholanthrene. The results (Table 1) showed that dimethylnitrosamine pretreatment measurably increased the rate of 14C02 excretion and in phenobarbitone-pretreated animals the 14C02 excretion rate was almost double the control value. On the other hand, no significant difference was observed in the metabolism of 14C-labelled dimethylnitrosamine in rats pretreated with 20-methylcholanthrene. Biochemical investigations on livers from pretreated rats showed that whereas dimethylnitrosamine pretreatment did not significantly alter the liver weight there was a marked depression in the microsomal cytochrome P-450 content and activities of some of the mixed-function-oxidase enzymes. Phenobarbitone treatment produced liver enlargement accompanied by induction of microsomal mixed-function-oxidase enzyme activity. Pretreatment with 20-methylcholanthrene did not enlarge the liver but induced microsomal mixed-function-oxidase enzyme activity.
The results of our present investigations show that in therat, over awide dose range of 14C-labelled dimethylnitrosamine, the rate of 14C02 excretion was dose-dependent and obeyed the Michaelis-Menten kineticequation, andalso that the 14C02 excretionrate was comparable for all the three parenteral and oral routes of administration. The gastrointestinal absorption studies clearly demonstrate that the small intestine was the major site of dimethylnitrosamine absorption.
Our findings with pretreated rats suggest that the metabolism of dimethylnitrosamine may not be wholly mediated by the hepatic microsomal cytochrome P-450-dependent mixed-function-oxidase enzyme system. Dimethylnitrosamine has been found to be a potent hepatocarcinogen in a variety of species of animals including the rat (Magee &Barnes, 1956). Metabolic studies in the rat using the 14C-labelled compound have established that dimethylnitrosamine is readily converted into COr and that the liver is mainly responsible for the metabolic degradation (Magee & Vandekar, 1958) . Further, investigations in vitro have shown that this process was mediated by the microsomal fraction and was dependent on NADPH and molecular O2 (Magee & Vandekar, 1958 
